P

Provention Bio Inc
F:2VB

Watchlist Manager
Provention Bio Inc
F:2VB
Watchlist
Price: 21.6 EUR -0.46% Market Closed
Market Cap: 2B EUR

Gross Margin
Provention Bio Inc

79.9%
Current
6%
Average
48.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
79.9%
=
Gross Profit
10.3m
/
Revenue
12.9m

Gross Margin Across Competitors

No Stocks Found

Provention Bio Inc
Glance View

Market Cap
1.9B EUR
Industry
Pharmaceuticals

Provention Bio Inc., a biopharmaceutical entity, emerged with a focused mission: pioneering the interception and prevention of immune-mediated diseases. The company identified a niche in the therapeutic landscape by addressing the root causes rather than merely managing symptoms. At its core, Provention Bio aimed to delay or halt the progression of autoimmune disorders, particularly Type 1 Diabetes (T1D), by leveraging immunotherapy. Their flagship product, teplizumab, stood as a testament to this strategy. This monoclonal antibody was designed to slow down the progression of T1D by modifying the immune system's response, thereby extending the period before insulin dependence begins in at-risk individuals. Rather than following the conventional path of reacting to fully manifested diseases, Provention Bio championed a proactive approach, capitalizing on early intervention. Financially, Provention Bio's business model revolved around developing and commercializing their innovative therapies, steering through regulatory approvals, and forming strategic partnerships. The company secured collaborations with larger pharmaceutical firms, like Sanofi, not only to bolster financial resources required for large-scale drug trials but also to leverage distribution channels once the therapies hit the market. Revenue streams were projected from licensing agreements, milestone payments, and, eventually, product sales upon successful commercialization. By addressing a significant unmet medical need, Provention Bio positioned itself to capitalize on the growing interest in disease prevention, while also offering hope to patients facing the realities of living with autoimmune diseases.

2VB Intrinsic Value
Not Available
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
79.9%
=
Gross Profit
10.3m
/
Revenue
12.9m
What is the Gross Margin of Provention Bio Inc?

Based on Provention Bio Inc's most recent financial statements, the company has Gross Margin of 79.9%.

Back to Top